Then we demonstrated that NDRG2 tumor-suppressor activity is mediated by the inhibition of cell cycle progression with increased accumulation of cancer cells in G1-phase and a corresponding reduction of cells in the S-phase of the cell cycle in the A-498 renal cancer cells. This evidence concerns the gene NDRG2 and cancer.